UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
322.89
-0.05 (-0.02%)
At close: Feb 6, 2026
UCB SA Market Cap
UCB SA has a market cap or net worth of $58.81 billion as of February 6, 2026. Its market cap has increased by 56.08% in one year.
Market Cap
58.81B
Enterprise Value
60.30B
Revenue
8.04B
Ranking
n/a
PE Ratio
37.59
Stock Price
$322.89
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 58.81B, an increase of 4,797.76%. That is a compound annual growth rate of 13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 58.81B | 10.48% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.55M |
| CytoDyn | 313.55M |
| Silence Therapeutics | 213.97M |
| Vaxart | 149.51M |
| BioStem Technologies | 112.90M |
| Nuo Therapeutics | 78.22M |
| HST Global | 74.26M |
| VitaSpring Biomedical | 51.78M |